-
1
-
-
33747451686
-
Glutamine: Role in gut protection in critical illness
-
Wischmeyer PE. Glutamine: role in gut protection in critical illness. Curr Opin Clin Nutr Metab Care 2006; 9:607-12.
-
(2006)
Curr Opin Clin Nutr Metab Care
, vol.9
, pp. 607-612
-
-
Wischmeyer, P.E.1
-
2
-
-
37849188556
-
Effect of glutamine on glutathione kinetics in vivo in dogs
-
Humbert B, Nguyen P, Martin L. Effect of glutamine on glutathione kinetics in vivo in dogs. J Nutr Biochem 2007; 18:10-6.
-
(2007)
J Nutr Biochem
, vol.18
, pp. 10-16
-
-
Humbert, B.1
Nguyen, P.2
Martin, L.3
-
3
-
-
0035053874
-
Cysteine metabolism and whole blood glutathione synthesis in septic pediatric patients
-
Lyons J, Rauh-Pfeiffer A, Ming-Yu Y, et al. Cysteine metabolism and whole blood glutathione synthesis in septic pediatric patients. Crit Care Med 2001; 29:870-7.
-
(2001)
Crit Care Med
, vol.29
, pp. 870-877
-
-
Lyons, J.1
Rauh-Pfeiffer, A.2
Ming-Yu, Y.3
-
4
-
-
0034941504
-
Oral feeding with glutamine prevents lymphcyte and glutathione depletion of Peyer's patches in endotoxemic mice
-
Manhart N, Vierlinger K, Spittler A, et al. Oral feeding with glutamine prevents lymphcyte and glutathione depletion of Peyer's patches in endotoxemic mice. Ann Surg 2001; 234:92-7.
-
(2001)
Ann Surg
, vol.234
, pp. 92-97
-
-
Manhart, N.1
Vierlinger, K.2
Spittler, A.3
-
5
-
-
0032034680
-
Alanyl-glutamine dipeptiven protected the liver function by increasing hepatic glutathione
-
Yu JC, Jiang ZM, Li DM. Alanyl-glutamine dipeptiven protected the liver function by increasing hepatic glutathione. Acta Acad Med Sin 1998; 20:103-9.
-
(1998)
Acta Acad Med Sin
, vol.20
, pp. 103-109
-
-
Yu, J.C.1
Jiang, Z.M.2
Li, D.M.3
-
6
-
-
2442494131
-
Glutamine: Recent developments in research on the clinical significance of glutamine
-
Melis GC, ter Wengel N, Boelens PG, et al. Glutamine: recent developments in research on the clinical significance of glutamine. Curr Opin Clin Nutr Metab Care 2004; 7:59-70.
-
(2004)
Curr Opin Clin Nutr Metab Care
, vol.7
, pp. 59-70
-
-
Melis, G.C.1
ter Wengel, N.2
Boelens, P.G.3
-
7
-
-
0019167355
-
Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine
-
Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 1980; 106:207-12.
-
(1980)
Anal Biochem
, vol.106
, pp. 207-212
-
-
Griffith, O.W.1
-
9
-
-
14944380669
-
Glutamine-dependent changes in gene expression and protein activity
-
Curi R, Lagranha CJ, Doi SQ, et al. Glutamine-dependent changes in gene expression and protein activity. Cell Biochem Funct 2005; 23:77-84.
-
(2005)
Cell Biochem Funct
, vol.23
, pp. 77-84
-
-
Curi, R.1
Lagranha, C.J.2
Doi, S.Q.3
-
10
-
-
34347204830
-
Effects of glutamine supplementation on gut barrier, glutathione content and acute phase response in malnourished rats during inflammatory shock
-
Belmonte L, Coeffier M, Le Pessot F. Effects of glutamine supplementation on gut barrier, glutathione content and acute phase response in malnourished rats during inflammatory shock. World J Gastroenterol 2007; 13:2833-40.
-
(2007)
World J Gastroenterol
, vol.13
, pp. 2833-2840
-
-
Belmonte, L.1
Coeffier, M.2
Le Pessot, F.3
-
12
-
-
0032731856
-
Glutathione status in critically-ill patients: Possibility of modulation by antioxidants
-
Wernerman J, Luo JL, Hammarqvist F. Glutathione status in critically-ill patients: possibility of modulation by antioxidants. Proc Nutr Soc 1999; 58:677-80.
-
(1999)
Proc Nutr Soc
, vol.58
, pp. 677-680
-
-
Wernerman, J.1
Luo, J.L.2
Hammarqvist, F.3
-
13
-
-
18344368289
-
Intestinal permeability and systemic infections in critically ill patients: Effect of glutamine
-
De-Souza DA, Greene LJ. Intestinal permeability and systemic infections in critically ill patients: effect of glutamine. Crit Care Med 2005; 33:1125-35.
-
(2005)
Crit Care Med
, vol.33
, pp. 1125-1135
-
-
De-Souza, D.A.1
Greene, L.J.2
-
14
-
-
13844254526
-
The role of glutamine in intensive care unit patients: Mechanisms of action and clinical outcome
-
Coeffier M, Dechelotte P. The role of glutamine in intensive care unit patients: mechanisms of action and clinical outcome. Nutr Rev 2005; 63:65-9.
-
(2005)
Nutr Rev
, vol.63
, pp. 65-69
-
-
Coeffier, M.1
Dechelotte, P.2
-
15
-
-
33644599450
-
L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: The French controlled, randomized, double-blind, multicenter study
-
Déchelotte P, Hasselmann M, Cynober L, et al. L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study. Crit Care Med 2006; 34: 598-604.
-
(2006)
Crit Care Med
, vol.34
, pp. 598-604
-
-
Déchelotte, P.1
Hasselmann, M.2
Cynober, L.3
-
16
-
-
34247871307
-
Optimizing the dose of glutamine dipeptides and antioxidants in critically ill patients: A phase I dose-finding study
-
Heyland DK, Dhaliwalm R, Day A. Optimizing the dose of glutamine dipeptides and antioxidants in critically ill patients: a phase I dose-finding study. JPEN J Parenter Enteral Nutr 2007; 31:109-18.
-
(2007)
JPEN J Parenter Enteral Nutr
, vol.31
, pp. 109-118
-
-
Heyland, D.K.1
Dhaliwalm, R.2
Day, A.3
|